Impact of Oat ( < em > Avena sativa < /em > L.) on Metabolic Syndrome and Potential Physiological Mechanisms of Action: A Current Review

J Agric Food Chem. 2023 Oct 5. doi: 10.1021/acs.jafc.3c02304. Online ahead of print.ABSTRACTOat (Avena sativa L.), an annual herbaceous plant belonging to the Gramineae family, is widely grown in various regions including EU, Canada, America, Australia, etc. Due to the nutritional and pharmacological values, oats have been developed into various functional food including fermented beverage, noodle, cookie, etc. Meanwhile, numerous studies have demonstrated that oats may effectively improve metabolic syndrome, such as dyslipidemia, hyperglycemia, atherosclerosis, hypertension, and obesity. However, the systematic pharmacological mechanisms of oats on metabolic syndrome have not been fully revealed. Therefore, in order to fully explore the benefits of oat in food industry and clinic, this review aims to provide up-to-date information on oat and its constituents, focusing on the effects on metabolic syndrome.PMID:37797345 | DOI:10.1021/acs.jafc.3c02304

Source: Atherosclerosis - October 5, 2023 Category: Cardiology Authors: Lin Li Ruiyuan Zhang Yichen Hu Hongdan Deng Xu Pei Fang Liu Chen Chen Source Type: research